Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

licensing agreement

8 posts
NNestlé
Nestlé and IdB Holding S.p.A. Enter Into Licensing Agreement for VOWST® in Europe
Read More

Nestlé and IdB Holding S.p.A. Enter Into Licensing Agreement for VOWST® in Europe

  • 2026-06-03
Collaboration aims to expand access for European patients to prevent recurrence of Clostridioides difficile infection (rCDI), a potentially…
RRoche
Roche, Medicines Patent Pool sign deal to expand access to influenza drug
Read More

Roche, Medicines Patent Pool sign deal to expand access to influenza drug

  • 2026-05-18
May 18 (Reuters) – Roche and the Medicines Patent Pool have signed a licensing agreement to expand access…
RRoche
MediLink Has Signed an Additional Exclusive Licensing Agreement with Roche
Read More

MediLink Has Signed an Additional Exclusive Licensing Agreement with Roche

  • 2026-05-13
SUZHOU, China, Jan. 8, 2026  /PRNewswire/ — MediLink Therapeutics (“MediLink”) today announced that it has entered into a…
NNovartis
Assessing Novartis (SWX:NOVN) Valuation After Positive Phase III Data And Upcoming Regulatory Milestones
Read More

Novartis Uses US Bond Issue To Expand RNA And Peptide Pipeline

  • 2026-04-07
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
RRoche
Starpharma Announces a Collaboration and License Agreement
Read More

Starpharma Announces a Collaboration and License Agreement

  • 2026-02-27
MELBOURNE, Australia, Sept. 22, 2025 (GLOBE NEWSWIRE) — Starpharma (ASX: SPL, US OTC: SPHRY), an innovative Australian biotechnology…
NNovartis
Novartis enters licensing agreement with UNP for peptide therapeutics
Read More

Novartis enters licensing agreement with UNP for peptide therapeutics

  • 2026-02-19
Novartis has signed a research partnership and licensing agreement with Unnatural Products (UNP) valued at up to $1.7bn…
NNovartis
BBC
Read More

Unnatural Products, Novartis sign licensing agreement for cardiovascular program

  • 2026-02-18
Wed, February 18, 2026 at 1:35 PM UTC A sign marks the Novartis Institutes for BioMedical Research facility…
NNovartis
Image for Lagarde's possible early departure leaves investors pondering replacements
Read More

Unnatural Products and Novartis Sign Heart Therapy

  • 2026-02-18
Editorial & Advertiser disclosure Global Banking & Finance Review® is an online platform offering news, analysis, and opinion…
Switzerland
www.europesays.com